G1 Therapeutics Inc (GTHX)
NASDAQ:GTHX
Holding GTHX?
Track your performance easily

G1 Therapeutics (GTHX) Income Statement

1,887 Followers

G1 Therapeutics Income Statement

Last quarter (Q2 2024), G1 Therapeutics's total revenue was $16.55M, a decrease of -60.97% from the same quarter last year. In Q2, G1 Therapeutics's net income was $-5.47M. See G1 Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 58.20M$ 82.51M$ 51.30M$ 31.48M$ 45.28M$ 0.00
Cost of Revenue
$ 2.33M$ 7.20M--$ 0.00-
Gross Profit
$ 55.86M$ 75.32M$ 51.30M$ 31.48M$ 45.28M-
Operating Expense
$ 96.08M$ 122.04M$ 187.48M$ 173.93M$ 141.76M$ 129.04M
Operating Income
$ -37.88M$ -39.53M$ -136.18M$ -142.46M$ -96.48M$ -129.04M
Net Non Operating Interest Income Expense
$ -6.70M$ 7.57M--$ -826.00K$ 6.58M
Other Income Expense
$ 1.48M$ 2.24M$ 9.68M$ 4.97M$ -542.00K$ 15.00K
Pretax Income
$ -42.96M$ -44.85M$ -145.86M$ -147.43M$ -97.84M$ -122.45M
Tax Provision
$ 1.81M$ 3.12M$ 1.70M$ 925.00K$ 1.41M$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -44.77M$ -47.97M$ -147.56M$ -148.35M$ -99.25M$ -122.45M
Basic EPS
$ -0.86$ -0.93$ -3.38$ -3.54$ -2.62$ -3.27
Diluted EPS
$ -0.91$ -0.93$ -3.38$ -3.54$ -2.62$ -3.27
Basic Average Shares
$ 208.27M$ 51.73M$ 43.63M$ 41.94M$ 37.88M$ 37.50M
Diluted Average Shares
$ 198.89M$ 51.73M$ 43.63M$ 41.94M$ 37.88M$ 37.50M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 96.08M$ 122.04M$ 187.48M$ 173.93M$ 141.76M$ 129.04M
Net Income From Continuing And Discontinued Operation
$ -44.77M$ -47.97M$ -147.56M$ -148.35M$ -99.25M$ -122.45M
Normalized Income
$ -29.20M-$ -115.23M-$ -99.25M$ -122.45M
Interest Expense
----$ 1.78M$ 0.00
EBIT
$ -34.16M$ -34.81M$ -145.86M$ -147.43M$ -96.07M$ -122.45M
EBITDA
$ -33.48M$ -34.30M$ -143.55M$ -145.84M$ -95.48M$ -122.09M
Currency in USD

G1 Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis